Anxiety

HEALTH INFORMATION

Identifying the gene-brain mechanisms that contribute to anxiety

WHAT WE KNOW

Anxiety disorder is a general term for frequent bouts of nervousness, fear, apprehension, or worrying, which appear without a reasonable cause. They can cause real, physical symptoms and affect how a person behaves. Anxiety can range from mild, which is vague and unsettling, to severe, which can be extremely debilitating and have a serious impact on daily life. Anxiety is considered a problem when the reaction that occurs is out of proportion to what my normally be expected.

Physical signs sometimes also include:

  • A pounding heart, tight chest or chest pain
  • Feeling short of breath
  • Dizzy, headache, sweaty, tingly, numb
  • Dry mouth, stomach pain

OUR LATEST RESEARCH

Genetics of normal brain function and links to anxiety and depression symptoms

Using various cognitive, psychological and neuroimaging measures, they have investigated the role of several genes known to be involved in brain disorders.

The TWIN-E study in emotion and cognition

The overall goal of this project is to establish the role of genetics versus environment for each measure of emotion and cognition, as well as resting state function, using twin modelling.

What else is happening in Anxiety research at NeuRA?

FEEL THE BUZZ IN THE AIR? US TOO.

'I've got the best job for you dad. Your shaky arm will be perfect for it!'

Children… honest and insightful. Their innocence warms the heart. But what words do you use to explain to a child that daddy has an incurable brain disease? What words tell them that in time he may not be able to play football in the park, let alone feed himself? What words help them understand that in the later stages, dementia may also strike? Aged just 36, this was the reality that faced Steve Hartley. Parkinson's disease didn't care he was a fit, healthy, a young dad and devoted husband. It also didn't seem to care his family had no history of it. The key to defeating Parkinson's disease is early intervention, and thanks to a global research team, led by NeuRA, we're pleased to announce that early intervention may be possible. Your support, alongside national and international foundations Shake it Up Australia and the Michael J Fox Foundation, researchers have discovered that a special protein, found in people with a family history of the disease increases prior to Parkinson’s symptoms developing. This is an incredible step forward, because it means that drug therapies, aimed at blocking the increase in the protein, can be administered much earlier – even before symptoms strike. The next step is to understand when to give the drug therapies and which people will most benefit from it. But we need your help. A gift today will support vital research and in time help medical professionals around the world treat Parkinson’s disease sooner, with much better health outcomes. Thank you, in advance, for your support.  
APPEAL